Managing multiple myeloma in 2023

Hear from leading experts in the field on how to identify, refer, and monitor patients with lymphoma, multiple myeloma, and ALL who receive treatment with CAR-T ...

Management of multiple myeloma-related renal impairment

Bortezomib-based regimens are the cornerstone of the management of patients with multiple myeloma and renal impairment at diagnosis. New quadruplet and triplet ...

Maintenance Therapy after Transplant: Multiple Myeloma | BMT Infonet

(04:50): Although we have many effective treatments for myeloma, as of 2023, we still don't have a cure. Treatment involves periods of response followed by ...

Management of multiple myeloma in a resource-constrained setting

Dr Henry Ddungu speaks with ecancer about how to manage multiple myeloma in resource-limited settings. Multiple myeloma is a common ...

Novel Approaches to the Treatment of Multiple Myeloma

Since the first positive trial displaying increased OS and event-free survival in patients with MM who received ASCT was published in 1996, high-dose ...

Multiple Myeloma: Transplant Eligible - Alberta Health Services

The following recommendations apply to adult cancer patients with multiple myeloma, who are transplant eligible. Recommendations. Treatment Guidelines for Newly ...

Lymphoma & Myeloma Clinical Trials - MD Anderson Cancer Center

... Treatment of High-Risk Smoldering Multiple Myeloma. 2023-0363 Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in ...

UConn Health Gives First US Dose of New Drug Offering Hope to ...

While the FDA gave accelerated approval to teclistamab on Oct. 25, 2022, to treat adults with multiple myeloma that has recurred after at least ...

Mezigdomide plus Dexamethasone in Relapsed and Refractory ...

The all-oral combination of mezigdomide plus dexamethasone showed promising efficacy in patients with heavily pretreated multiple myeloma.

Multiple Myeloma | Jefferson Health

Our best-in-class multiple myeloma team creates personalized treatment plans that include support and resources to meet your physical and emotional needs.

From Bench to Bedside: New Frontiers in Multiple Myeloma

In 2021, the FDA approved the CAR T-cell therapy idecabtagene vicleucel (ide-cel, Abecma) for the treatment of adult patients with multiple ...

The Management of Multiple Myeloma in a Renal Transplant Recipient

Subsequently, the treatment was switched to daratumumab + KD (carfilzomib – dexamethasone) as described in the CANDOR study (11). During the ...

Approaching and managing relapsed high-risk myeloma - VJHemOnc

SOHO 2023 | Approaching and managing relapsed high-risk myeloma. Marc Braunstein • 1 Sep 2023. SOHO 2023 · Multiple Myeloma Antibodies Bortezomib CAR-T ...

Multiple Myeloma - Dana-Farber Cancer Institute

The Multiple Myeloma Program within the Hematologic Oncology Treatment Center includes physicians, clinicians, and research scientists who work together on ...

Can multiple myeloma be cured? Treatments and outlook

The treatment approach focuses on slowing its progression, improving symptoms, and putting the disease into remission. Doctors consider multiple ...

Multiple Myeloma Relapse: Rate, Treatment and Life Expectancy

Stem cell transplant: For patients with a long-lasting remission (two to three years) after an autologous stem cell transplant, a second stem cell transplant ...

Treatment of Multiple Myeloma: Best Practices from The MD ...

A panel of expert physicians from satellite clinics of MD Anderson review recent updates in the treatment of multiple myeloma and discuss how emerging evidence ...

Relapsed myeloma: treatment options and how to find the best one

Blood Health Q3 2023. Relapsed myeloma ... Enormous advances have been made in the treatment of multiple myeloma, particularly in the past decade.

Multiple myeloma

One simple breakthrough treatment isn't enough when every patient is unique. That's why we're pursuing a portfolio of immunotherapies that ...

Multiple myeloma - Symptoms and causes - Mayo Clinic

mSMART. https://www.msmart.org/mm-treatment-guidelines. Accessed March 29, 2023. mSMART Mayo stratification for myeloma and risk-adapted therapy ...